Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
D015121:6-Ketoprostaglandin F1 alpha / Q000494:pharmacology*; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D002260:Carboprost / Q000494:pharmacology*; D011464:Epoprostenol / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology*; D011460:Prostaglandins F / Q000494:pharmacology*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology*; D011817:Rabbits; D013917:Thrombin / Q000494:pharmacology
D011453:Prostaglandins; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic; D015121:6-Ketoprostaglandin F1 alpha; D000244:Adenosine Diphosphate; D002260:Carboprost; D011464:Epoprostenol; D013917:Thrombin